BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20638028)

  • 21. Therapy of hepatitis C in HIV-coinfection.
    Rockstroh JK; Vogel M
    Eur J Med Res; 2004 Jun; 9(6):304-8. PubMed ID: 15257871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of immunosuppression and chemotherapy on reactivation of viral hepatitis.
    Fallahian F; Alavian SM; Fallahian V; Zamani F
    Saudi J Kidney Dis Transpl; 2010 Jul; 21(4):621-7. PubMed ID: 20587863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
    Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S
    J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of chronic hepatitis B: recommendations from an Italian workshop.
    Carosi G; Rizzetto M
    Dig Liver Dis; 2008 Aug; 40(8):603-17. PubMed ID: 18499540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
    Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human immunodeficiency virus and hepatitis B and C coinfection: pathogenic interactions, natural history, and therapy.
    Kim AY; Chung RT; Polsky B
    AIDS Clin Rev; 2000-2001; ():263-306. PubMed ID: 10999223
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of hepatitis C virus/HIV coinfection.
    Chun S; Sherman KE
    Clin Liver Dis; 2005 Aug; 9(3):525-33, ix. PubMed ID: 16023981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG; Monteiro M; Rehm J
    Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis D.
    Husa P; Linhartová A; Nemecek V; Husová L
    Acta Virol; 2005; 49(4):219-25. PubMed ID: 16402678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus infection: co-infection with hepatitis C virus, hepatitis D virus, and human immunodeficiency virus.
    Shukla NB; Poles MA
    Clin Liver Dis; 2004 May; 8(2):445-60, viii. PubMed ID: 15481349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.
    Puoti M; Airoldi M; Bruno R; Zanini B; Spinetti A; Pezzoli C; Patroni A; Castelli F; Sacchi P; Filice G; Carosi G
    AIDS Rev; 2002; 4(1):27-35. PubMed ID: 11998781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The implications of antiviral drugs with activity against hepatitis B virus and HIV.
    Bottecchia M; Garcia-Samaniego J; Soriano V
    Curr Opin Infect Dis; 2007 Dec; 20(6):621-8. PubMed ID: 17975413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part 2.
    Boyle BA
    AIDS Read; 2001 Aug; 11(8):387-90, 397. PubMed ID: 11570261
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
    Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
    Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641
    [No Abstract]   [Full Text] [Related]  

  • 35. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
    ; McCaughan GW; Omata M; Amarapurkar D; Bowden S; Chow WC; Chutaputti A; Dore G; Gane E; Guan R; Hamid SS; Hardikar W; Hui CK; Jafri W; Jia JD; Lai MY; Wei L; Leung N; Piratvisuth T; Sarin S; Sollano J; Tateishi R
    J Gastroenterol Hepatol; 2007 May; 22(5):615-33. PubMed ID: 17444847
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are HIV-infected patients candidates for liver transplantation?
    Samuel D; Weber R; Stock P; Duclos-Vallée JC; Terrault N
    J Hepatol; 2008 May; 48(5):697-707. PubMed ID: 18331763
    [No Abstract]   [Full Text] [Related]  

  • 39. Outcomes among patients with end-stage liver disease who are coinfected with HIV and hepatitis C virus.
    Neff GW; Shire NJ; Rudich SM
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S50-5. PubMed ID: 16265614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Seroprevalence of delta virus and hepatitis C virus in patients with chronic infection with hepatitis B virus].
    de Miguel J; Collazos J; Mayo J; López de Goicoechea MJ; Echániz C; Mendarte U
    Rev Clin Esp; 1994 Oct; 194(10):897-900. PubMed ID: 7800870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.